copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Beacon Biosignals Beacon’s AI-powered technology is bringing precision neuroscience to clinical trials and accelerating drug development for unmet medical needs, so life-changing treatments can reach patients faster
Syndeio Biosciences Announces Clinical Collaboration with Beacon . . . Beacon Biosignals’ analytics platform combines its large clinical EEG databases and proprietary machine-learning algorithms to identify neurobiomarkers that assist with patient stratification, assessing drug activity and therapeutic efficacy
Beacon Biosignals The Beacon Datastore is the brain of the Beacon Platform, making it easy to store, access, and analyze millions of hours of biosignal data Uploading data to the Datastore allows it to integrate with all of Beacon’s products for powerful analysis and insights
Beacon Biosignals Acquires Dreem, Launches At-home Sleep Monitoring . . . Beacon's platform excels in sleep EEG analytics, providing macroarchitecture assessments via automated sleep scoring and intricate microarchitecture analysis of features like arousals and spindles— delivering deep insights into sleep quality
Beacon Biosignals Announces Strategic Collaboration with Skye . . . This partnership will incorporate sleep quality and sleep apnea endpoints via the Beacon Platform and the FDA 510 (k)-cleared Dreem 3S EEG device to better understand the comprehensive impact of Nimacimab on patients with obesity
Beacon Biosignals Beacon Biosignals Announces Strategic Collaboration with Skye Bioscience to Integrate Sleep Quality and Sleep Apnea Endpoints in CBEYOND™ Phase 2 Trial of Nimacimab for Obesity
Beacon Biosignals and Takeda Launch Strategic Collaboration to Advance . . . Beacon Biosignals is the leading at-home EEG platform for precision drug development Its FDA 510 (k)-cleared Dreem 3S EEG headband algorithms enable and accelerate research and development of treatments that transform the lives of patients with neurological, psychiatric, and sleep disorders
Beacon Biosignals We move with urgency—because every moment matters Faster decisions, faster trials, and faster insights mean getting life-changing treatments to patients sooner We protect time for rest, sleep, and life Your energy fuels your impact—inside and outside of Beacon
Beacon Biosignals Raises $86M to Accelerate AI-Driven Insights into . . . Beacon Biosignals is unlocking the power of brain data to advance human health The company combines FDA-cleared wearable EEG technology with advanced AI to capture and analyze real-world neural data, enabling breakthroughs across neurology, psychiatry, and sleep medicine